Antiretroviral Drugs Market Outlook- Increasing Investments for Research in Healthcare Industry to Drive The Global Antiretroviral Drugs Market By A CAGR Of Around 6% Throughout 2020-2028
Research Nester has published a report titled “Antiretroviral Drugs Market: Global Demand Analysis & Opportunity Outlook 2028” which delivers detailed overview of the antiretroviral drugs market in terms of market segmentation by drug type and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
The antiretroviral therapy is a medical prescription that treats HIV. This drug is not used to kill or cure this virus, but rather stop the growth of this virus. The antiretroviral drugs market is anticipated to record a CAGR of around 6% over the forecast period, i.e., 2020-2028. Based on drug type, the market is segmented into protease inhibitors, integrase inhibitors, multi-class combination products, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs) and others, out of which, multi-class combination products segment is anticipated to hold the largest market share on the back of the better clinical outcome and replacing the conventional treatment method which involve multiple tablets. The increasing sale of this multi class combination tablets are expected to give the fuel to the growth of this segment in the global antiretroviral drugs market.
The antiretroviral drugs market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The region of North America is estimated to hold the largest share of this market owing to the high ART coverage rate and growing R&D activity in this region is increasing the demand of this market and anticipated to hold the high CAGR during the forecast period. On the other hand, In Latin America it is anticipated to hold the second largest share in this drug market during the forecast period on the back of increasing number cases, which in turn increasing the demand of this market. In Asia pacific the market is growing at a tremendous rate on account of increasing cases among people of this region, especially in India and China.
Growing Investments for R&D in the Healthcare Industry
The increasing concern for the chronic diseases affecting individuals worldwide is raising the need amongst the healthcare operators to continuously put up their efforts for the development of advanced healthcare products that can help humanity to fight against the deadly diseases. As such, several governments of nations worldwide are increasingly spending on research and developments. Similar advancements are also observed for the manufacturing of medicines and treatments for HIV disease, which is also anticipated to drive the demand for antiretroviral drugs, and in turn the growth of the market.
However, increasing portfolio of this drug is anticipated to hamper the market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the antiretroviral drugs market which includes company profiling of Roche Holding AG(SWX: RO), Gilead Sciences Inc.(NASDAQ: GILD), GlaxoSmithKline(NYSE: GSK), Bristol-Myers-Squibb(NYSE: BMY), Abbott Laboratories(NYSE: ABT), AstraZeneca plc(LON: AZN), Merck & Co.(NYSE: MRK), Johnson and Johnson(NYSE: JNJ) and Novartis international AG(SWX: NOVN). The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the antiretroviral drugs market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.